Pluribus Labs’s Avista AVA Stock Holding History

Pluribus Labs’s Portfolio AVA Stock Details AVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-6,593	Closed	-$280K	–	65
2021 Q4	$280K	Buy	+6,593	New	+$265K	0.3%	143

Other funds holding AVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $32.1B AUM 31.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pluribus Labs's AVA Position: Q1 2022 in Review

Pluribus Labs sold out of Avista (AVA) in Q1 2022, closing a stake of 6,593 shares — an estimated $280K sold.

Pluribus Labs first reported a position in AVA in Q4 2021 and held it in 1 quarter. The position peaked at $280K in Q4 2021. 275 funds tracked by Wall St. Rank hold AVA as of Q1 2022.

Pluribus Labs reported no remaining Avista position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 6,593 Avista shares in Q1 2022, an estimated $280K.
Pluribus Labs first reported a position in Avista in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Avista position peaked at $280K in Q4 2021.
275 funds tracked by Wall St. Rank held Avista as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.